Core Viewpoint - The company reported a slight increase in revenue and net profit for the first half of 2025, but experienced a decline in the second quarter, indicating challenges in maintaining growth momentum in a competitive market [1][4]. Financial Performance - For the first half of 2025, the company achieved revenue of 13.88 billion yuan, a year-on-year increase of 0.5%, and a net profit attributable to shareholders of 366 million yuan, up 2.5% year-on-year [1]. - In Q2 2025, the company reported revenue of 4.73 billion yuan, a decline of 14.2% year-on-year, and a net profit of 1.33 billion yuan, down 11.6% year-on-year [1]. Product Performance - In H1 2025, the revenue breakdown by product series showed that the Year Original Liquor generated 10.96 billion yuan (up 1.6%), Gujing Gongjiu 1.18 billion yuan (down 4.4%), and Huanghelou 1.50 billion yuan (up 6.7%) [2]. - The Year Original Liquor accounted for 80.34% of total liquor revenue, reflecting a slight increase of 0.02 percentage points year-on-year [2]. Regional Performance - Revenue by region in H1 2025 indicated a decline in North China (8.09 billion yuan, down 27.0%), while Central China (12.30 billion yuan, up 3.6%) and South China (7.68 billion yuan, down 5.8%) showed mixed results [2]. - The number of distributors in North China increased by 18, while South China decreased by 6, and Central China decreased by 32 compared to the end of 2024 [2]. Sales Channels - Online sales grew significantly, with revenue of 573 million yuan in H1 2025, up 40.2%, while offline sales were 13.31 billion yuan, down 0.7% [2]. - The company optimized sales expenses by reducing promotional costs and increasing online advertising expenditure by 49.7% [3]. Profitability - The gross profit margin for H1 2025 was 79.9%, a decrease of 0.54 percentage points year-on-year, while Q2 2025 gross profit margin was 80.2%, down 0.26 percentage points [3]. - The net profit margin for H1 2025 was 25.9%, an increase of 0.50 percentage points year-on-year, and for Q2 2025, it was 28.1%, up 0.83 percentage points [3]. Strategic Initiatives - The company is focusing on online channel development and has launched a new product, 26° "Light Ancient 20", targeting younger consumers with a lower alcohol content [4]. - The company is leveraging digital marketing and partnerships with mainstream media to enhance brand visibility and drive online sales [4]. Future Outlook - The company projects revenue of 26.04 billion yuan and 28.89 billion yuan for 2025 and 2026, respectively, with expected year-on-year growth of 10.4% and 10.9% [4]. - The forecast for net profit attributable to shareholders is 6.24 billion yuan and 7.08 billion yuan for 2025 and 2026, respectively, with growth rates of 13.2% and 13.4% [4].

Core Insights - The company reported a decline in revenue and net profit for the first half of 2025, with total revenue of 863 million yuan, down 8.2% year-on-year, and a net profit of 230 million yuan, down 32.5% [1] - The second quarter of 2025 showed a revenue increase of 5.9% to 562 million yuan, but net profit decreased by 26.7% to 138 million yuan [1] - The company has optimized its product structure and achieved significant results in online channel transformation, with online revenue increasing by 47.1% to 695 million yuan [1][2] Financial Performance - Medical device revenue was 238 million yuan, down 48.1%, with a gross margin of 84.2%, up 2.9 percentage points [1] - Cosmetics revenue reached 625 million yuan, up 30.0%, with a gross margin of 80.4%, down 1.1 percentage points [1] - Overall gross margin for the first half of 2025 was 81.5%, up 0.1 percentage points, while net profit margin was 26.6%, down 9.6 percentage points [1] Expense Analysis - Selling, administrative, and R&D expense ratios were 48.7%, 5.5%, and 2.7%, respectively, with year-on-year increases of 16.6 percentage points, 0.7 percentage points, and 1.0 percentage points [1] - The increase in selling expenses was attributed to higher personnel costs and increased promotional efforts, while financial expenses decreased by 26.06 million yuan due to reduced interest income from funds used for investment [1] R&D and Market Position - The company has made progress in its R&D pipeline, having obtained approvals for various medical devices and completed product design for a new collagen filler [2] - The company is focusing on upstream raw material research, with new innovative peptides and other materials under development, aiming to establish competitive advantages [2] - The company achieved the highest national repurchase rate for efficacy cosmetics in 2024 and has maintained the top sales position for domestic sheet masks for five consecutive years [2] Investment Outlook - The company’s online channel transformation is showing significant results, and it is expected to continue strengthening its R&D capabilities in high-barrier fields [2] - Projected net profits for 2025-2027 are 576 million yuan, 647 million yuan, and 745 million yuan, with corresponding price-to-earnings ratios of 24.5, 21.8, and 19.0 [2]

Summary of H&H Holdings Conference Call Industry Overview - The global dietary supplement (VDS) market is experiencing steady growth, with a market size of approximately $132.4 billion in 2023 and an annual growth rate of 4%-5% [2][7] - The Chinese health supplement market is growing significantly faster than the global average, with a compound annual growth rate (CAGR) of 8%-9% from 2010 to 2023, increasing from over 70 billion yuan to around 224 billion yuan [2][7] - The health supplement industry in China benefits from aging demographics and new consumption trends, with online sales channels accelerating, rising to 60% post-pandemic [2][9] Company Insights - H&H Holdings has transformed into a health supplement company primarily focused on adult health, with over 90% of Swisse brand revenue coming from online channels, maintaining a market share of 7%-8% [2][11] - The company has diversified its brand matrix by launching new brands targeting teenagers, children, and pets, such as Swisse Me, Little Swisse, and Plus [2][11] - H&H Holdings is actively expanding its oral beauty product line, including high-margin products like super light bottles and anti-sugar pills, which are expected to enhance profitability [2][14] Financial Performance and Projections - H&H Holdings is expected to optimize interest expenses by approximately 100 million yuan in 2025 through the replacement of high-interest dollar debt with domestic low-interest loans, which will directly enhance profits [2][5][21] - The company anticipates an adjusted net profit of around 700 million yuan in 2025, representing a nearly 30% year-on-year growth, indicating a turning point in its fundamentals [2][23] - The company’s revenue structure has shifted, with a 24%-25% decline in milk powder revenue in 2024 due to regulatory changes, but a recovery of 44% in the first quarter of 2025 is expected [2][13][14] Market Strategy and Brand Development - H&H Holdings is focusing on the Southeast Asian market for expansion, aiming to replicate the success of the Swisse brand in this region [2][20][27] - The company’s management team has extensive experience in fast-moving consumer goods (FMCG) and foreign investment, which supports strategic clarity and revenue stability across different phases [2][16] - The Swisse brand has expanded its core family nutrition series to include oral beauty products, which are expected to drive future growth [2][15] Risk Assessment - The company has a high level of goodwill, approximately 7.8 billion yuan, primarily concentrated in the Swisse and pet brands, which are performing well with no significant impairment risks [2][22] - Legal issues are not expected to significantly impact the company's financial status, as past experiences suggest a favorable outcome in similar cases [2][25] Conclusion - H&H Holdings is positioned for significant growth in the health supplement market, with a strong focus on online sales and brand diversification. The company’s financial outlook is positive, with expectations of increased profitability and market expansion, particularly in Southeast Asia. The management's strategic decisions and market positioning provide a solid foundation for future growth [2][26][27]